HEADER TRANSFERASE 08-DEC-21 7QGB TITLE H. SAPIENS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP- TITLE 2 COMPETITIVE INHIBITOR 5,6-DIBROMOBENZOTRIAZOLE AT PH 6.5 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II SUBUNIT ALPHA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CK II ALPHA; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK2A1, CK2A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS CK2, CASEIN KINASE 2, INHIBITOR, BROMO-BENZOTRIAZOLE, HALOGEN BOND, KEYWDS 2 TRANSFERASE-INHIBITOR COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.WINIEWSKA-SZAJEWSKA,H.CZAPINSKA,M.KAUS-DROBEK,A.PIASECKA, AUTHOR 2 K.MIECZKOWSKA,M.DADLEZ,M.BOCHTLER,J.POZNANSKI REVDAT 3 31-JAN-24 7QGB 1 REMARK REVDAT 2 23-NOV-22 7QGB 1 JRNL REVDAT 1 19-OCT-22 7QGB 0 JRNL AUTH M.WINIEWSKA-SZAJEWSKA,H.CZAPINSKA,M.KAUS-DROBEK,A.FRICKE, JRNL AUTH 2 K.MIECZKOWSKA,M.DADLEZ,M.BOCHTLER,J.POZNANSKI JRNL TITL COMPETITION BETWEEN ELECTROSTATIC INTERACTIONS AND HALOGEN JRNL TITL 2 BONDING IN THE PROTEIN-LIGAND SYSTEM: STRUCTURAL AND JRNL TITL 3 THERMODYNAMIC STUDIES OF 5,6-DIBROMOBENZOTRIAZOLE-HCK2 ALPHA JRNL TITL 4 COMPLEXES. JRNL REF SCI REP V. 12 18964 2022 JRNL REFN ESSN 2045-2322 JRNL PMID 36347916 JRNL DOI 10.1038/S41598-022-23611-0 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.CZAPINSKA,M.WINIEWSKA-SZAJEWSKA,A.SZYMANIEC-RUTKOWSKA, REMARK 1 AUTH 2 A.PIASECKA,M.BOCHTLER,J.POZNANSKI REMARK 1 TITL HALOGEN ATOMS IN THE PROTEIN-LIGAND SYSTEM. STRUCTURAL AND REMARK 1 TITL 2 THERMODYNAMIC STUDIES OF THE BINDING OF BROMOBENZOTRIAZOLES REMARK 1 TITL 3 BY THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2. REMARK 1 REF J PHYS CHEM B V. 125 2491 2021 REMARK 1 REFN ISSN 1520-5207 REMARK 1 PMID 33689348 REMARK 1 DOI 10.1021/ACS.JPCB.0C10264 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.WINIEWSKA,K.KUCINSKA,M.MAKOWSKA,J.POZNANSKI,D.SHUGAR REMARK 1 TITL THERMODYNAMICS PARAMETERS FOR BINDING OF HALOGENATED REMARK 1 TITL 2 BENZOTRIAZOLE INHIBITORS OF HUMAN PROTEIN KINASE CK2ALPHA. REMARK 1 REF BIOCHIM BIOPHYS ACTA V.1854 1708 2015 REMARK 1 REFN ISSN 0006-3002 REMARK 1 PMID 25891901 REMARK 1 DOI 10.1016/J.BBAPAP.2015.04.004 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.WINIEWSKA,M.MAKOWSKA,P.MAJ,M.WIELECHOWSKA,M.BRETNER, REMARK 1 AUTH 2 J.POZNANSKI,D.SHUGAR REMARK 1 TITL THERMODYNAMIC PARAMETERS FOR BINDING OF SOME HALOGENATED REMARK 1 TITL 2 INHIBITORS OF HUMAN PROTEIN KINASE CK2. REMARK 1 REF BIOCHEM BIOPHYS RES COMMUN V. 456 282 2015 REMARK 1 REFN ESSN 1090-2104 REMARK 1 PMID 25450618 REMARK 1 DOI 10.1016/J.BBRC.2014.11.072 REMARK 1 REFERENCE 4 REMARK 1 AUTH S.KASPEROWICZ,E.MARZEC,A.M.MACIEJEWSKA,D.TRZYBINSKI, REMARK 1 AUTH 2 M.BRETNER,K.WOZNIAK,J.POZNANSKI,K.MIECZKOWSKA REMARK 1 TITL A COMPETITION BETWEEN HYDROPHOBIC AND ELECTROSTATIC REMARK 1 TITL 2 INTERACTIONS IN PROTEIN-LIGAND SYSTEMS. BINDING OF REMARK 1 TITL 3 HETEROGENEOUSLY HALOGENATED BENZOTRIAZOLES BY THE CATALYTIC REMARK 1 TITL 4 SUBUNIT OF HUMAN PROTEIN KINASE CK2. REMARK 1 REF IUBMB LIFE V. 72 1211 2020 REMARK 1 REFN ESSN 1521-6551 REMARK 1 PMID 32162783 REMARK 1 DOI 10.1002/IUB.2271 REMARK 2 REMARK 2 RESOLUTION. 2.58 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0103 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.58 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.43 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 15875 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : THIN RESOLUTION SHELLS REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 791 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.58 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.72 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2270 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.87 REMARK 3 BIN R VALUE (WORKING SET) : 0.2930 REMARK 3 BIN FREE R VALUE SET COUNT : 88 REMARK 3 BIN FREE R VALUE : 0.3700 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2806 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 22 REMARK 3 SOLVENT ATOMS : 268 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 46.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.97000 REMARK 3 B22 (A**2) : 0.97000 REMARK 3 B33 (A**2) : -1.94000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.507 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.279 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.234 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.636 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.953 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.914 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3087 ; 0.007 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2888 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4198 ; 1.172 ; 1.953 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6633 ; 0.878 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 365 ; 5.433 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 172 ;33.599 ;23.081 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 551 ;14.040 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 31 ;14.296 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 425 ; 0.070 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3562 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 789 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 HYDROGEN ATOMS HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 3 U VALUES : REFINED INDIVIDUALLY REMARK 3 THE RELATIVE OCCUPANCIES OF STATICALLY DISORDERED RESIDUES HAVE REMARK 3 BEEN ASSIGNED TENTATIVELY. REMARK 3 THE RADIATION DAMAGE TRIGGERED COVALENT BOND BETWEEN THE SECOND REMARK 3 LIGAND MOLECULE (AWAY FROM THE ACTIVE SITE) AND THE PROTEIN WAS REMARK 3 CONSIDERED BUT NOT BUILT. REMARK 3 THERE ARE A FEW DENSITY CLUSTERS THAT MAY CORRESPOND TO SOLVENT REMARK 3 MOLECULES BUT UNAMBIGUOUS DISTINCTION BETWEEN VARIOUS BUFFER REMARK 3 COMPONENTS WAS NOT STRAIGHTFORWARD AND THUS THE WATER MOLECULES REMARK 3 WERE RETAINED IN THE FINAL MODEL. REMARK 4 REMARK 4 7QGB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-DEC-21. REMARK 100 THE DEPOSITION ID IS D_1292117700. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-NOV-16 REMARK 200 TEMPERATURE (KELVIN) : 100.000 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PETRA III, DESY REMARK 200 BEAMLINE : P11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91170 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16669 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.580 REMARK 200 RESOLUTION RANGE LOW (A) : 45.430 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 26.00 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.30800 REMARK 200 FOR THE DATA SET : 12.6300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.58 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 26.42 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 2.06500 REMARK 200 FOR SHELL : 1.990 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3WAR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.73 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20 MM SODIUM FORMATE, 20 MM AMMONIUM REMARK 280 ACETATE, 20 MM SODIUM CITRATE TRIBASIC DIHYDRATE, 20 MM SODIUM REMARK 280 POTASSIUM TARTRATE TETRAHYDRATE, 20 MM SODIUM OXAMATE, 20% REMARK 280 POLYETHYLENE GLYCOL 550 MONOMETHYL ESTER, 10% POLYETHYLENE REMARK 280 GLYCOL 20 000, AND 0.1 M BUFFERING SOLUTION OF IMIDAZOLE/MES PH REMARK 280 6.5, PH 6.50, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 42 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 64.24350 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 64.24350 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 30.61950 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 64.24350 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 64.24350 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 30.61950 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 64.24350 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 64.24350 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 30.61950 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 64.24350 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 64.24350 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 30.61950 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 637 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 677 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLY A 335 REMARK 465 SER A 336 REMARK 465 SER A 337 REMARK 465 SER A 338 REMARK 465 MET A 339 REMARK 465 PRO A 340 REMARK 465 GLY A 341 REMARK 465 GLY A 342 REMARK 465 SER A 343 REMARK 465 THR A 344 REMARK 465 PRO A 345 REMARK 465 VAL A 346 REMARK 465 SER A 347 REMARK 465 SER A 348 REMARK 465 ALA A 349 REMARK 465 ASN A 350 REMARK 465 MET A 351 REMARK 465 MET A 352 REMARK 465 SER A 353 REMARK 465 GLY A 354 REMARK 465 ILE A 355 REMARK 465 SER A 356 REMARK 465 SER A 357 REMARK 465 VAL A 358 REMARK 465 PRO A 359 REMARK 465 THR A 360 REMARK 465 PRO A 361 REMARK 465 SER A 362 REMARK 465 PRO A 363 REMARK 465 LEU A 364 REMARK 465 GLY A 365 REMARK 465 PRO A 366 REMARK 465 LEU A 367 REMARK 465 ALA A 368 REMARK 465 GLY A 369 REMARK 465 SER A 370 REMARK 465 PRO A 371 REMARK 465 VAL A 372 REMARK 465 ILE A 373 REMARK 465 ALA A 374 REMARK 465 ALA A 375 REMARK 465 ALA A 376 REMARK 465 ASN A 377 REMARK 465 PRO A 378 REMARK 465 LEU A 379 REMARK 465 GLY A 380 REMARK 465 MET A 381 REMARK 465 PRO A 382 REMARK 465 VAL A 383 REMARK 465 PRO A 384 REMARK 465 ALA A 385 REMARK 465 ALA A 386 REMARK 465 ALA A 387 REMARK 465 GLY A 388 REMARK 465 ALA A 389 REMARK 465 GLN A 390 REMARK 465 GLN A 391 REMARK 465 LEU A 392 REMARK 465 GLU A 393 REMARK 465 HIS A 394 REMARK 465 HIS A 395 REMARK 465 HIS A 396 REMARK 465 HIS A 397 REMARK 465 HIS A 398 REMARK 465 HIS A 399 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 118 40.54 -81.89 REMARK 500 ARG A 155 -8.64 77.04 REMARK 500 ASP A 175 78.85 49.90 REMARK 500 ALA A 193 168.58 61.45 REMARK 500 MET A 208 56.59 -95.86 REMARK 500 TYR A 211 -37.89 -35.95 REMARK 500 HIS A 234 79.80 -106.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 766 DISTANCE = 5.90 ANGSTROMS REMARK 525 HOH A 767 DISTANCE = 6.79 ANGSTROMS REMARK 525 HOH A 768 DISTANCE = 7.11 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6TLP RELATED DB: PDB REMARK 900 HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE REMARK 900 INHIBITOR DIBROMOBENZOTRIAZOLE (5,6-DBBT) AT PH 7.5 REMARK 900 RELATED ID: 6TLL RELATED DB: PDB REMARK 900 HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE REMARK 900 INHIBITOR 4,5,6,7-TETRABROMOBENZOTRIAZOLE (TBBT) AT PH 7.5 DBREF 7QGB A 1 391 UNP P68400 CSK21_HUMAN 1 391 SEQADV 7QGB LEU A 392 UNP P68400 EXPRESSION TAG SEQADV 7QGB GLU A 393 UNP P68400 EXPRESSION TAG SEQADV 7QGB HIS A 394 UNP P68400 EXPRESSION TAG SEQADV 7QGB HIS A 395 UNP P68400 EXPRESSION TAG SEQADV 7QGB HIS A 396 UNP P68400 EXPRESSION TAG SEQADV 7QGB HIS A 397 UNP P68400 EXPRESSION TAG SEQADV 7QGB HIS A 398 UNP P68400 EXPRESSION TAG SEQADV 7QGB HIS A 399 UNP P68400 EXPRESSION TAG SEQRES 1 A 399 MET SER GLY PRO VAL PRO SER ARG ALA ARG VAL TYR THR SEQRES 2 A 399 ASP VAL ASN THR HIS ARG PRO ARG GLU TYR TRP ASP TYR SEQRES 3 A 399 GLU SER HIS VAL VAL GLU TRP GLY ASN GLN ASP ASP TYR SEQRES 4 A 399 GLN LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SER GLU SEQRES 5 A 399 VAL PHE GLU ALA ILE ASN ILE THR ASN ASN GLU LYS VAL SEQRES 6 A 399 VAL VAL LYS ILE LEU LYS PRO VAL LYS LYS LYS LYS ILE SEQRES 7 A 399 LYS ARG GLU ILE LYS ILE LEU GLU ASN LEU ARG GLY GLY SEQRES 8 A 399 PRO ASN ILE ILE THR LEU ALA ASP ILE VAL LYS ASP PRO SEQRES 9 A 399 VAL SER ARG THR PRO ALA LEU VAL PHE GLU HIS VAL ASN SEQRES 10 A 399 ASN THR ASP PHE LYS GLN LEU TYR GLN THR LEU THR ASP SEQRES 11 A 399 TYR ASP ILE ARG PHE TYR MET TYR GLU ILE LEU LYS ALA SEQRES 12 A 399 LEU ASP TYR CYS HIS SER MET GLY ILE MET HIS ARG ASP SEQRES 13 A 399 VAL LYS PRO HIS ASN VAL MET ILE ASP HIS GLU HIS ARG SEQRES 14 A 399 LYS LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU PHE TYR SEQRES 15 A 399 HIS PRO GLY GLN GLU TYR ASN VAL ARG VAL ALA SER ARG SEQRES 16 A 399 TYR PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR GLN MET SEQRES 17 A 399 TYR ASP TYR SER LEU ASP MET TRP SER LEU GLY CYS MET SEQRES 18 A 399 LEU ALA SER MET ILE PHE ARG LYS GLU PRO PHE PHE HIS SEQRES 19 A 399 GLY HIS ASP ASN TYR ASP GLN LEU VAL ARG ILE ALA LYS SEQRES 20 A 399 VAL LEU GLY THR GLU ASP LEU TYR ASP TYR ILE ASP LYS SEQRES 21 A 399 TYR ASN ILE GLU LEU ASP PRO ARG PHE ASN ASP ILE LEU SEQRES 22 A 399 GLY ARG HIS SER ARG LYS ARG TRP GLU ARG PHE VAL HIS SEQRES 23 A 399 SER GLU ASN GLN HIS LEU VAL SER PRO GLU ALA LEU ASP SEQRES 24 A 399 PHE LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SER ARG SEQRES 25 A 399 LEU THR ALA ARG GLU ALA MET GLU HIS PRO TYR PHE TYR SEQRES 26 A 399 THR VAL VAL LYS ASP GLN ALA ARG MET GLY SER SER SER SEQRES 27 A 399 MET PRO GLY GLY SER THR PRO VAL SER SER ALA ASN MET SEQRES 28 A 399 MET SER GLY ILE SER SER VAL PRO THR PRO SER PRO LEU SEQRES 29 A 399 GLY PRO LEU ALA GLY SER PRO VAL ILE ALA ALA ALA ASN SEQRES 30 A 399 PRO LEU GLY MET PRO VAL PRO ALA ALA ALA GLY ALA GLN SEQRES 31 A 399 GLN LEU GLU HIS HIS HIS HIS HIS HIS HET 7M0 A 401 11 HET 7M0 A 402 11 HETNAM 7M0 5,6-DIBROMOBENZOTRIAZOLE HETSYN 7M0 DIBROMO-2-BENZOTRIAZOLE FORMUL 2 7M0 2(C6 H3 BR2 N3) FORMUL 4 HOH *268(H2 O) HELIX 1 AA1 PRO A 20 ASP A 25 1 6 HELIX 2 AA2 TYR A 26 HIS A 29 5 4 HELIX 3 AA3 LYS A 74 ARG A 89 1 16 HELIX 4 AA4 ASP A 120 LEU A 124 5 5 HELIX 5 AA5 THR A 129 MET A 150 1 22 HELIX 6 AA6 LYS A 158 HIS A 160 5 3 HELIX 7 AA7 SER A 194 LYS A 198 5 5 HELIX 8 AA8 GLY A 199 VAL A 204 1 6 HELIX 9 AA9 TYR A 211 ARG A 228 1 18 HELIX 10 AB1 ASP A 237 GLY A 250 1 14 HELIX 11 AB2 THR A 251 ASN A 262 1 12 HELIX 12 AB3 ARG A 268 GLY A 274 1 7 HELIX 13 AB4 ARG A 280 VAL A 285 5 6 HELIX 14 AB5 ASN A 289 VAL A 293 5 5 HELIX 15 AB6 SER A 294 LEU A 305 1 12 HELIX 16 AB7 ASP A 308 ARG A 312 5 5 HELIX 17 AB8 THR A 314 GLU A 320 1 7 HELIX 18 AB9 HIS A 321 TYR A 323 5 3 HELIX 19 AC1 PHE A 324 MET A 334 1 11 SHEET 1 AA1 6 GLY A 34 ASN A 35 0 SHEET 2 AA1 6 LEU A 97 LYS A 102 1 O ILE A 100 N GLY A 34 SHEET 3 AA1 6 PRO A 109 GLU A 114 -1 O ALA A 110 N VAL A 101 SHEET 4 AA1 6 GLU A 63 ILE A 69 -1 N VAL A 66 O PHE A 113 SHEET 5 AA1 6 VAL A 53 ASN A 58 -1 N ASN A 58 O GLU A 63 SHEET 6 AA1 6 TYR A 39 LEU A 45 -1 N VAL A 42 O GLU A 55 SHEET 1 AA2 2 ILE A 152 MET A 153 0 SHEET 2 AA2 2 GLU A 180 PHE A 181 -1 O GLU A 180 N MET A 153 SHEET 1 AA3 2 VAL A 162 ASP A 165 0 SHEET 2 AA3 2 LYS A 170 LEU A 173 -1 O LYS A 170 N ASP A 165 CISPEP 1 GLU A 230 PRO A 231 0 -8.08 CRYST1 128.487 128.487 61.239 90.00 90.00 90.00 P 42 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007783 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007783 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016329 0.00000